Be The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths – Business Wire

MINNEAPOLIS & EL SEGUNDO, Calif.--(BUSINESS WIRE)--Be The Match BioTherapies, an organization offering solutions for companies developing and commercializing cell and gene therapies, and NantKwest (Nasdaq: NK), a next generation, clinical-stage immunotherapy company focused on harnessing the unique power of the immune system using natural killer (NK) cells to treat cancer and infectious diseases, today announced an agreement through which Be The Match BioTherapies is providing donor material for a NantKwest Phase 1b clinical trial to address acute respiratory distress syndrome (ARDS), one of the primary causes of COVID-19 deaths. The agreement combines Be The Match BioTherapies ability to provide high-quality cellular source material from the worlds largest registry of volunteer donors with NantKwests capabilities in manufacturing off-the-shelf cell therapies

Read more
Can stem cell therapy help – Greater Kashmir

Currently definitive treatment against civid is unavailable while patients are being offered palliative treatment to manage symptoms. Many known therapeutic agents like antivirals (Remdesivir or Hydroxychloroquine) or antiparasitic (Ivermectin) are being evaluated for their efficacy against the disease, although without any comprehensive success

Read more
Cell Freezing Media for Cell Therapy Market to Exhibit Impressive Growth of CAG – News by aeresearch

The recent report on Cell Freezing Media for Cell Therapy market provides an end-to-end assessment of this business sphere and comprises of important data regarding the pivotal parameters such as prevailing market trends, current revenue, market share, industry size, periodic deliverables, and profit estimates over the forecast duration. New latest Growth Report on Cell Freezing Media for Cell Therapy Market Size, Share | Industry Segment by Applications (Human Embryonic Stem Cells, CAR-T Cell Therapy, Neural Stem Cell Therapy, Mesenchymal Stem Cell Therapy, Hematopoietic Stem Cell Transplantation and Other), by Type (With FBS and Without FBS), Regional Outlook, Market Demand, Latest Trends, Industry Growth & Revenue by Manufacturers, Company Profiles & Forecasts to 2025.

Read more
Global Stem Cell Therapy Market Forecast & Opportunities, 2025 – ResearchAndMarkets.com – Business Wire

DUBLIN--(BUSINESS WIRE)--The "Global Stem Cell Therapy Market By Type (Allogeneic, Autologous, Syngeneic), By Source of Stem Cells (Adipose Tissue, Bone Marrow, Neural, Embryo/Cord Blood derived, iPSCs, Others), By Application, By End Users, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering. The Global Stem Cell Therapy Market is expected to grow at a formidable rate of around 12% during the forecast period. The industry is segmented based on type, source of stem cells, application, end-users, company and region

Read more
Lockheed Martin Steps Up To Help Save Lives And Support Be The Match During COVID-19 – Southernminn.com

MINNEAPOLIS, May 14, 2020 /PRNewswire/ --The challenges surrounding COVID-19 have impacted every aspect of healthcare, including ensuring the timely delivery of bone marrow and blood stem cells for transplant. Thanks to the generosity of the Lockheed Martin Corporation, however, patients are able to continue receiving life-saving transplants without interruption. When the National Marrow Donor Program (NMDP)/Be The Match ran out of available European Union couriers to deliver life-saving cells to American patients and with tens of thousands of commercial flights canceled, Lockheed Martin stepped up to offer their corporate aircraft as an in-kind donation to support the federal government's COVID-19 response and relief efforts to ensure patients that life-saving products from European donors would arrive on time

Read more
Hospitals to Resume Elective Surgeries, Triggering a Surge in Blood Needs – southsoundtalk.com

Submitted by Bloodworks Northwest With new COVID-19 cases in the Northwest projected to decline in the weeks ahead, Washington and Oregon hospitals are preparing to re-start surgeries, organ transplants and cancer treatments that were suspended in March after the magnitude of the pandemic threat became apparent. Patient needs and requests for blood from Bloodworks healthcare partners are rising quickly and could reach pre-COVID levels as early as next week before the blood supply is ready. Whenthe coronavirus hit, donors in the community stepped up immediately, said CurtBailey, President and CEO of Bloodworks Northwest

Read more
Cell Therapy Shows Promise in Parkinson’s – MedPage Today

Dopaminergic progenitor cells derived from a Parkinson's disease patient's own skin cells and injected into his putamen showed evidence of survival and were associated with improved motor scores and quality of life measures. The cells were implanted into the 69-year-old Parkinson's patient's putamen in two procedures, left hemisphere followed by right hemisphere, 6 months apart. PET imaging with a dopaminergic activity tracer up to 24 months suggested graft survival, reported Jeffrey Schweitzer, MD, PhD, of Massachusetts General Hospital, and colleagues, in the New England Journal of Medicine.

Read more